10.07.20 ijBio Portfolio

Pharm Involved.

$1,000,000 on 12.06.20 Changes for 10.07.20:

AstraZeneca (AZN) $51,3 $53,8 (+4.9%) $104,900

Inovio (INO) $13,2 $23,4 (+77.3%) $177,300

Moderna (MRNA)$61,5 $62,6 (+1.8%) $101,800

Abbot (ABT) $88,5 $93 (+5%) $105,000

Gilead (GILD) $72,5.  $76,3 (+5.2%) $105,200

Adaptive (ADPT) $42,2.  $45,9 (+8.8%) $108,800

CytoDyn (CYDY) $3,12 $4,73 (+51.6%) $151,600

AbbVie (ABBV) $92,2 $96,8 (+5%) $105,000

Arcus (RCUS) $27,3 $24,4 (-10.6%) $89,400

Sorrento (SRNE) $4,6  $8,06 (+75,2%) $175,200

At close 10.07.20= $ 1,224,200 (-1.75%)

per million dollars at 10% per share.

previous day

during the week 03-10.06.2020: +0.3%

At close 09.07.20= $ 1,245,900 (+0.63%)

At close 08.07.20= $1,238,100 (-1.46%)

At close 07.07.20= $1,256,400 (+1.34%)

At close 06.07.20= $1,239,700 (+1.6%)

At close 02.07.20= $1,220,500

during the week 26-03.06.2020: -4.6%

At close 26.06.20= $1,279,600

during the week 19-26.06.2020:+21%

At close 19.06.20= $1,057,700

during the week 12-19.06 +5.7%

12.06.20 = $1,000,000

Global Communication Platforms portfoilio

--

Portfolio News:

Australia Warns of Vaccine Wait; Tokyo Cases Surge: Virus Update

Sorrento Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Sorrento Therapeutics, Inc. To Contact The Fir

Australia's Victoria state records another day of high coronavirus infections

U.S. Cases Rise 1.9%; California Deaths Up Again: Virus Update

HHS allocates Gilead's COVID-19 drug remdesivir to four hardest hit states

Stock Market Today: Gilead Gives Stocks a Booster Shot

Market Recap: Friday, July 10

Gilead's Remdesivir Cuts Risk of COVID-19 Death by 62% -- Maybe

Gilead Says Its Coronavirus Drug Lowers The Risk Of Death; Shares Pop

CANADA FX DEBT-Canadian dollar recovers from 10-day low after record jobs gain

Dow ends nearly 370 points higher as Nasdaq logs another record close

CORRECTED-US STOCKS-Wall St climbs as Gilead data offsets virus fears; Nasdaq hits another record high close

FOREX-U.S. dollar slides as vaccine news offsets surge in virus cases

US STOCKS-Wall St gains as Gilead data offsets virus fears; Dow leads gains

TREASURIES-Longer-term yields climb on optimism about COVID-19 recovery

Gilead says coronavirus drug remdesivir can reduce risk of death, but analysts need more proof

Pfizer and BioNTech's Coronavirus Vaccine Ready for Regulatory Submission in December, Maybe Earlier

Dow jumps as Gilead says drug reduces COVID-19 death risk

AbbVie (ABBV) Gets FDA Nod for Another Botox Label Expansion

Kiplinger's Weekly Earnings Calendar (7/13-7/17): JNJ, JPM, NFLX

Top Analyst Reports for Oracle, Abbott & Chevron

Stocks Rebound and Wipe Out Morning Losses. Gilead Lifts Hopes.

Pfizer's Debt Overview

The U.S. Is Bailing Out Companies. Regeneron Doesn’t Need the Help.

A Look Into Gilead Sciences Deb

US companies seeking capital during pandemic test bank market's new normal

Stock Markets Open Mixed Friday as Netflix Gets Upgraded, Gilead Reports Positive Coronavirus Treatment Results

Infojet Club

With help but without the assistance of Yahoo Finance

Advertise With Us